Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 2360 Records) |
Query Trace: Breast Neoplasms and BRCA1[original query] |
---|
Comparing Prognosis for BRCA1, BRCA2, and Non-BRCA Breast Cancer. Cancers 2023 12 15 (23): . Pedro Antunes Meireles, Sofia Fragoso, Teresa Duarte, Sidónia Santos, Catarina Bexiga, Priscila Nejo, Ana Luís, Beatriz Mira, Isália Miguel, Paula Rodrigues, Fátima V |
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan. Breast cancer (Tokyo, Japan) 2023 12 . Bo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, Yen-Shu Lin, Chin-Jung Feng, Yen-Jen Chen, Han-Fang Cheng, Chun-Yu Liu, Ta-Chung Chao, Jiun-I Lai, Ling-Ming Tseng, Chi-Cheng Hua |
Breast cancers in monoallelic MUTYH germline mutation carriers have clinicopathological features overlapping with those in BRCA1 germline mutation carriers. Breast cancer research and treatment 2023 12 . Aysenur Keske, Paul Weisman, Monica Ospina-Romero, Prachi Raut, Kelcy Smith-Simmer, Anna L Zakas, Christopher Flynn, Jin |
Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction. Breast (Edinburgh, Scotland) 2023 12 73 103615. Anja Tüchler, Antoine De Pauw, Corinna Ernst, Amélie Anota, Inge M M Lakeman, Julia Dick, Nienke van der Stoep, Christi J van Asperen, Monika Maringa, Natalie Herold, Britta Blümcke, Robert Remy, Anke Westerhoff, Denise J Stommel-Jenner, Eléonore Frouin, Lisa Richters, Lisa Golmard, Nadine Kütting, Chrystelle Colas, Barbara Wappenschmidt, Kerstin Rhiem, Peter Devilee, Dominique Stoppa-Lyonnet, Rita K Schmutzler, Eric Hahn |
Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients. Breast cancer research and treatment 2023 12 . Mieke C Zwager, Iris Holt-Kedde, Hetty Timmer-Bosscha, Geertruida H de Bock, Paul M N Werker, Carolien P Schröder, Bert van der Vegt, Marlous Arjaa |
A Novel Germline Mutation of BRCA1 and Integrated Analysis With Somatic Mutation in a Chinese Multi-Cancer Family. The oncologist 2023 12 . Xiling Yang, Li Shang, Liren Yang, Landi Sun, Xiaoqian Tuo, Sijia Ma, Le Zhao, Xu Li, Wenfang Ya |
Survival outcomes of patients with HER2/neu-positive breast cancer with germline BRCA mutations. Cancer 2023 12 . Fatma Nihan Akkoc Mustafayev, Mihir Amitabh Shukla, Amanda Lanier, Denái R Milton, Angelica M Gutierrez, Stephen K Gruschkus, John E Lewis, Rashmi K Murthy, Banu K Ar |
Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study. Breast cancer research : BCR 2023 12 25 (1): 152. Han-Fang Cheng, Yi-Fang Tsai, Chun-Yu Liu, Chih-Yi Hsu, Pei-Ju Lien, Yen-Shu Lin, Ta-Chung Chao, Jiun-I Lai, Chin-Jung Feng, Yen-Jen Chen, Bo-Fang Chen, Jen-Hwey Chiu, Ling-Ming Tseng, Chi-Cheng Hua |
Cost-Effectiveness Analysis of Adjuvant Olaparib Versus Watch and Wait in the Treatment of Germline BRCA1/2-Mutated, High-Risk, HER2-Negative Early Breast Cancer in Sweden. PharmacoEconomics - open 2023 12 . Maria Polyzoi, Mattias Ekman, Anja Reithmeier, Johanna Jacob, Emma Karlsson, Evelina Bertranou, Barbro Linderholm, Robert Hett |
Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer. JCO precision oncology 2023 12 7 e2300338. Synnøve Yndestad, Christina Engebrethsen, Andrea Herencia-Ropero, Oleksii Nikolaienko, Olav K Vintermyr, Reidun K Lillestøl, Laura Minsaas, Beryl Leirvaag, Gjertrud T Iversen, Bjørnar Gilje, Egil S Blix, Helge Espelid, Steinar Lundgren, Jürgen Geisler, Hildegunn S Aase, Turid Aas, Einar G Gudlaugsson, Alba Llop-Guevara, Violeta Serra, Emiel A M Janssen, Per E Lønning, Stian Knappskog, Hans P Eikesd |
BRCA1/2 mutation carriers vs the general breast cancer population (N?=?799,986): 21-gene assay-based molecular characterization. Breast cancer research and treatment 2024 4 . Rinat Yerushalmi, Adi Pomerantz, Ron Lewin, Shani Paluch-Shimon, Lior Soussan-Gutman, Frederick L Baehner, Hillary Voet, Avital Bareket-Samish, Inbal Kedar, Yael Goldberg, Tamar Peretz-Yablonski, Luna Kadou |
Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area. BMC cancer 2024 4 24 (1): 411. Zhiyuan Wu, Qingyun Zhang, Yiting Jin, Xinju Zhang, Yanli Chen, Can Yang, Xuemei Tang, Haowen Jiang, Xiaoyi Wang, Xinli Zhou, Feng Yu, Bing Wang, Ming Gu |
Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants. JAMA network open 2024 4 7 (4): e247421. Zhenzhen Zhang, Shangyuan Ye, Sarah M Bernhardt, Heidi D Nelson, Ellen M Velie, Virginia F Borges, Emma R Woodward, D Gareth R Evans, Pepper J Sched |
Real-world evaluation of deep learning algorithms to classify functional pathogenic germline variants. medRxiv : the preprint server for health sciences 2024 4 . Ryan D Chow, Ravi B Parikh, Katherine L Nathans |
Targeted genotyping for recurring variants in cancer susceptibility genes in non-Ashkenazi Jewish patients with breast cancer diagnosed ?50 years. Cancer 2024 4 . Rinat Bernstein-Molho, Narmeen Abu Shhada, Yael Laitman, Iris Netzer, Shelley Shoval, Eitan Friedm |
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer. NPJ breast cancer 2024 4 10 (1): 28. Stefania Morganti, Qingchun Jin, Julie Vincuilla, Ryan Buehler, Sean Ryan, Samantha Stokes, Tonia Parker, Elizabeth A Mittendorf, Tari A King, Anna Weiss, Ann H Partridge, Brittany L Bychkovsky, Giuseppe Curigliano, Nabihah Tayob, Nancy U Lin, Judy E Garber, Sara M Tolaney, Filipa Lyn |
Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases. Breast cancer (Tokyo, Japan) 2024 4 . Alexandre De Moura, Delphine Loirat, Sarah Vaillant, Sinen Korbi, Nicolas Kiavue, Diana Bello Roufai, Laurence Escalup, Romain Desmaris, Pauline Vaflard, Paul Cottu, Jean-Yves Pierga, François-Clément Bidard, Luc Cabel, Alexandre Acram |
Genetic contribution of breast cancer genes in women of black African origin. Frontiers in genetics 2024 1 14 1302645. Rokhaya Ndiaye, Jean Pascal Demba Diop, Ahmadou Dem, Alioune Die |
Copper Chaperone for Superoxide Dismutase Subtypes as a Prognostic Marker in Luminal B Breast Cancer. Clinical Medicine Insights. Oncology 2024 1 18 11795549231219239. Yanping Li, Wenfei Du, Rui Yang, Xiaonan Wei, Haibin Li, Xiaoyuan Zha |
BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer. Cell death discovery 2024 1 10 (1): 5. Chae Min Lee, Yeseong Hwang, Jae Woong Jeong, Minki Kim, Janghee Lee, Soong June Bae, Sung Gwe Ahn, Sungsoon Fa |
Optical Genome Mapping Reveals the Landscape of Structural Variations and Their Clinical Significance in HBOC-Related Breast Cancer. Frontiers in bioscience (Landmark edition) 2024 1 29 (1): 2. Yanan Cheng, Li Dong, Dechao Bu, Lei Han, Yi Zhao, Juntian Liu, Xiaojing Guo, Hanli Xu, Jinpu |
BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients. BMC medical genomics 2024 1 17 (1): 3. Yinmei Zhang, Heming Wu, Caiyan Gan, Hui Rao, Qiuming Wang, Xueming G |
BRCA mutation status and pathological characterization of breast cancer in Zhoushan Islands, China. The Journal of international medical research 2024 1 52 (1): 3000605231223426. Shuhui Bao, Nini Sun, Yaling Li, Jiaojie Shu, Jing Xu, Yong Zhang, Xia Q |
Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions. Annals of surgical oncology 2024 1 . Alison Laws, Saskia Leonard, Emma Hershey, Samantha Stokes, Julie Vincuilla, Eshita Sharma, Kara Milliron, Judy E Garber, Sofia D Merajver, Tari A King, Melissa L Pilewsk |
Association of Genetic Markers with the Risk of Early-Onset Breast Cancer in Kazakh Women. Genes 2024 1 15 (1): . Liliya Skvortsova, Saltanat Abdikerim, Kanagat Yergali, Natalya Mit, Anastassiya Perfilyeva, Nazgul Omarbayeva, Aigul Zhunussova, Zulfiya Kachiyeva, Tolkyn Sadykova, Bakhytzhan Bekmanov, Dilyara Kaidarova, Leyla Djansugurova, Gulnur Zhunusso |
Increased risk of contralateral breast cancer for BRCA1/2 wild-type, high-risk Korean breast cancer patients: a retrospective cohort study. Breast cancer research : BCR 2024 1 26 (1): 14. Eunhye Kang, Ji-Jung Jung, Changjin Lim, Hong-Kyu Kim, Han-Byoel Lee, Wonshik Han, Hyeong-Gon Mo |
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer. Journal of gynecologic oncology 2024 1 . Hua Yuan, Lin Xiu, Ning Li, Yifan Li, Lingying Wu, Hongwen Y |
Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing. Pathology, research and practice 2024 1 254 155075. Seref Bugra Tuncer, Betul Celik, Seda Kilic Erciyas, Ozge Sukruoglu Erdogan, Busra Kurt Gültaslar, Demet Akdeniz Odemis, Mukaddes Avsar, Fatma Sen, P?nar Mualla Saip, Hulya Yazi |
Radiation-Induced Lymphopoenia and Treatment Outcome in Hereditary Breast Cancer Patients. Folia biologica 2024 1 69 (3): 91-98. So?a Argalácsová, ?udmila K?ížová, Martin Mat?j?, Dominika Svobodová, Michal Vo? |
Checkpoint Kinase 2 (CHEK2) Gene Mutation in a Patient With Breast and Prostate Cancer: A Unique Presentation of a Rare Disease. Cureus 2024 1 15 (11): e49710. Samar N Ekram, Nasser Al Shanbari, Bassam M Bin Laswad, Abdulrahman Alharthi, Waseem Tayeb, Abdulbari Bah |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: